In our study, ITIH3 levels were higher in the bladder and upper urinary tract carcinoma groups than in the cystitis and healthy control groups, suggesting that ITIH3 may be highly expressed in the urine of urothelial carcinoma patients and that high levels of ITIH3 may regulate the occurrence of bladder cancer. Here, ITIH3 is linked to urothelial carcinoma.